Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience

Conti, A; Peccerillo, F; Amerio, P; Balato, A; Bardazzi, F; Bianchi, L; Burlando, M; Cannavò, Sp; Chiricozzi, A; Dapavo, P; De Simone, C; Fargnoli, Mc; Gambardella, A; Gisondi, P; Malagoli, P; Malara, G; Mugheddu, C; Offidani, Am; Piaserico, S; Prignano, F; Stingeni, L; Pellacani, G